Course Topics
Info
Knowledge Center

Do you know how to prepare for a ‘best practice’ optimization of your brand’s lifecycle management strategies?

(by Neal Hansen, expert-trainer of
the Optimizing Brand Lifecycle Management Strategies course
)

Good lifecycle management (LCM) can be defined as:

“Maximizing the potential of a molecule in the context of the overall portfolio. As such, it is the process of knowing which questions to ask and effectively making go/no-go decisions at every stage of the product lifecycle”

 

The main challenges pharma faces in managing the lifecycles of their brands are:
  • Development times getting longer, as concerns about safety move up on the regulator's agenda
  • Extending patent life has become more challenging because defensible patenting and regulator exclusivities are increasingly limited
  • The drug approval rate is under pressure as a result of increasing focus on safety
  • Product uptake slowing down because of pricing and reimbursement hurdles and more restrictive treatment guidelines (e.g. NICE)
  • The level of market penetration, and therefore the peak sales potential, is reduced by the presence of more and better competing drugs on the market
  • Therapeutic substitution results in an earlier sales decline in the brand’s lifecycle
lifecycle management optimization
You should first ask yourself 3 questions before even engaging in developing an LCM plan:
  • When: what timing should be considered?
  • Who: who should drive the process, and who should make the decisions?
  • How: are you going for a formalised team or have it integrated in the existing structure; will it be a core process or an add-on?
Once you have answered the above 3 questions, you will have to gather the necessary critical assets:
  • Strong market intelligence
  • Involvement of the leadership team
  • Buy-in of both marketing and development
  • Creativity and flexibility (‘out of the box’ thinking)
  • Strong corporate memory (previous ideas and strategies)
In later stages of a product’s lifecycle, evidence of a well-managed product lifecycle should include:
  • A defined positioning of the brand in both the pre- and post-patent expiry period
  • A portfolio of lifecycle management options (developmental, commercial, regulatory) available to affiliates to adopt a tailored approach to patent expiry
  • Affiliate level action plans to manage the brand/molecule in the patent expiry period that recognize the local dynamics likely to shape the new competitive environment

A good preparation will allow you to optimize your different LCM strategies when marketing your brand in today’s challenging market.

 


 

 

© C.E.L.forpharma 2008 - Sitemap - Design: Hans Robberechts - Creation: www.norvan.info